People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SiO2 Medical Products, Inc. | — | Pharmaceuticals | Series C | $48.0M | $1.7B | 2019 |
Robert S. Abrams at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert S. Abrams on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert S. Pangborn | 1 | 1 |
| John S. Belfance | 1 | 1 |
| Jean-Marie S. Painvin | 1 | 1 |
| Thomas S. Strungmann | 1 | 1 |
| Jared S. Morris | 1 | 1 |
| John S. Stein | 1 | 1 |
| Melissa S. Simon | 1 | 1 |
| Anthony S. Rosenberg | 1 | 1 |
| Helmut S. Jeggle | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.